NON-INVASIVE MONITORING OF EGFR MUTATIONS IN NONSMALL CELL LUNG CANCER (NSCLC) DURING TARGETED THERAPY: STATE OF THE ART AND OUR EXPERIENCE. (2016). Voprosy Onkologii, 62(4), 513-518. https://doi.org/10.37469/0507-3758-2016-62-4-513-518